[Webinar] Implications Across the Health Care System of the New Federal Drug Price Regulation

September 22nd, 1:00 pm - 2:00 pm ET
Manatt, Phelps & Phillips, LLP

Manatt, Phelps & Phillips, LLP

September 22nd, 2022
1:00 PM - 2:00 PM ET

The Inflation Reduction Act of 2022 (IRA) includes the most dramatic change to U.S. drug price regulation in history. The new law allows the federal government to “negotiate” the price of many drugs dispensed to Medicare beneficiaries, imposes penalties on drug manufacturers for increasing prices faster than inflation, and redesigns the Medicare Part D prescription drug benefit.

In a new webinar, Manatt Health projects how the IRA will impact each sector of the interconnected U.S. health care system. Click here to register free—and earn CLE. Key topics the program will cover include:

  • The impact on brand drug manufacturers’ research incentives and financial obligations
  • How generic and biosimilar manufacturers may reprioritize strategies
  • The changes for health care providers, especially those that administer drugs to patients
  • The interaction with the 340B prescription drug discount program for safety net providers
  • Reactions from payers, pharmacy benefit managers, pharmacies and state Medicaid agencies

Even if you can’t attend our live session on September 22, click here to register free now and you’ll receive a link to view the webinar on demand.

NOTE: If you missed our first webinar on the IRA, “Preparing for Change: A Guide to the Inflation Reduction Act Drug Pricing Provisions,” click here to view the program free on demand and download a free copy of the presentation.



CLE is pending in NY and CA.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Manatt, Phelps & Phillips, LLP | Attorney Advertising


Manatt, Phelps & Phillips, LLP

Manatt, Phelps & Phillips, LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.